414 results on '"Macbeth, F."'
Search Results
2. SABR-5 Results Are Not Reliable in Assessing Improvement or Maintenance of Quality of Life Without Comparable Evaluation in Control Patients.
3. Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer: comment
4. Radiotherapy and the Challenge of Palliation
5. PulMiCC was Not ‘Unsuccessful’ and Stereotactic Ablative Body Radiotherapy is Not Like a Parachute: Comments on the Editorial by Ostler et al.
6. Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy – No
7. The GILDA trial finds no survival benefit from intensified screening after primary resection of colorectal cancer: the PulMiCC trial tests the survival benefit of pulmonary metastasectomy for detected asymptomatic lung metastases
8. Is Concurrent Chemoradiation the Standard of Care for Locally Advanced Non-small Cell Lung Cancer? A Review of Guidelines and Evidence
9. Prediction of venous thromboembolism in lung cancer patients receiving chemotherapy: OR130
10. Reporting of studies based on the analysis of routinely collected health data
11. NICE Guidelines: management of colorectal cancer metastases
12. Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients – control survival is much better than previously assumed
13. Local treatment of ‘Oligometastases’: Wishful thinking is not supported by available evidence
14. Management of mesh complications following surgery for stress urinary incontinence or pelvic organ prolapse: a systematic review
15. Primary surgical management of anterior pelvic organ prolapse: a systematic review, network meta‐analysis and cost‐effectiveness analysis
16. P2.16-02 Randomising Patients into Trials of Thoracic Cancer Surgery: An Analysis of Patient and Cancer Team Behaviour in Practice
17. Diagnostic and therapeutic uses of anti-idiotype antibody in the management of human B-cell lymphoma
18. Radiotherapy and the Challenge of Palliation
19. Decision analysis in NSCLC
20. Primary surgical management of anterior pelvic organ prolapse: a systematic review, network meta‐analysis and cost‐effectiveness analysis.
21. Management of mesh complications following surgery for stress urinary incontinence or pelvic organ prolapse: a systematic review.
22. Problems Of The Oncology Outpatient: Role Of The Liaison Health Visitor
23. Adjuvant Tamoxifen For Operable Carcinoma Of The Breast [With Reply]
24. Management Of Lung Cancer [with Reply]
25. Melanoma: Summary of updated NICE guidelines
26. Meta-analysis of colorectal cancer follow-up after potentially curative resection
27. Stereotactic Ablative Radiotherapy for ‘Oligometastases’: a Treatment in Search of Evidence
28. Percutaneous Image Guided Thermal Ablation (IGTA) therapies are to be included in the interventional arm of the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) trial to test if survival and quality of life are better than with intention to treat without intervention
29. Is there a survival benefit from increased intensity of CEA monitoring after primary resection of colorectal cancer?
30. Re-launch of PulMiCC trial to discover the true effect of pulmonary metastasectomy on survival in advanced colorectal cancer
31. VM26: Phase I and II studies
32. Community? What do you mean? An investigation into how differing understandings of the term ‘community’ shapes care-leavers’ move to independence
33. Weighing and Including Different Types Of Knowledge (WINDTOK) in guideline development
34. Stereotactic Body Radiotherapy for Pulmonary Metastases
35. Metastasectomy for Sarcoma
36. Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer
37. Diaries of evidence-based tutors: beyond 'numbers needed to teach'
38. Pulmonary metastasectomy in colorectal cancer: Time for a trial
39. Guidelines should reflect all knowledge, not just clinical trials
40. NICE calls for a register
41. Response to C. Faivre-Finn et al.’s Reply to: Is Concurrent Chemoradiation the Standard of Care for Locally Advanced Non-small Cell Lung Cancer? A Review of Guidelines and Evidence
42. Hard choices: a qualitative study of influences on the treatment decisions made by advanced lung cancer patients
43. A tale of woe
44. NICE reply
45. Antithrombotic therapy and survival in patients with malignant disease
46. Histoptysis or oncoptysis: suggested terms for tissue expectoration
47. Atypical facial pain as the first presentation of mediastinal relapse in lung cancer
48. Advanced Breast Cancer: Diagnosis and Treatment. National Institute for Health and Clinical Excellence Guideline 2009 — a Solid Basis for Good Clinical Practice
49. Erlotinib for the treatment of relapsed non-small cell lung cancer
50. Cryotherapy and high intensity focused ultrasound for prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.